Annual Revenue
$607.52 M
-$59.72 M-8.95%
December 31, 2023
Summary
- As of February 7, 2025, SUPN annual revenue is $607.52 million, with the most recent change of -$59.72 million (-8.95%) on December 31, 2023.
- During the last 3 years, SUPN annual revenue has risen by +$87.12 million (+16.74%).
- SUPN annual revenue is now -8.95% below its all-time high of $667.24 million, reached on December 31, 2022.
Performance
SUPN Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
$175.69 M
+$7.36 M+4.37%
September 30, 2024
Summary
- As of February 7, 2025, SUPN quarterly revenue is $175.69 million, with the most recent change of +$7.36 million (+4.37%) on September 30, 2024.
- Over the past year, SUPN quarterly revenue has increased by +$21.81 million (+14.17%).
- SUPN quarterly revenue is now -0.94% below its all-time high of $177.35 million, reached on September 30, 2022.
Performance
SUPN Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM Revenue
$651.97 M
+$21.81 M+3.46%
September 30, 2024
Summary
- As of February 7, 2025, SUPN TTM revenue is $651.97 million, with the most recent change of +$21.81 million (+3.46%) on September 30, 2024.
- Over the past year, SUPN TTM revenue has increased by +$41.44 million (+6.79%).
- SUPN TTM revenue is now -2.47% below its all-time high of $668.50 million, reached on March 31, 2023.
Performance
SUPN TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
SUPN Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -8.9% | +14.2% | +6.8% |
| 3 y3 years | +16.7% | +14.2% | +6.8% |
| 5 y5 years | +48.6% | +14.2% | +6.8% |
SUPN Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -8.9% | +4.8% | -0.9% | +29.6% | -2.5% | +12.4% |
| 5 y | 5-year | -8.9% | +54.7% | -0.9% | +85.0% | -2.5% | +66.0% |
| alltime | all time | -8.9% | >+9999.0% | -0.9% | +2136.7% | -2.5% | +7658.2% |
Supernus Pharmaceuticals Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $175.69 M(+4.4%) | $651.97 M(+3.5%) |
| Jun 2024 | - | $168.32 M(+17.2%) | $630.16 M(+5.5%) |
| Mar 2024 | - | $143.64 M(-12.6%) | $597.40 M(-1.7%) |
| Dec 2023 | $607.52 M(-8.9%) | $164.31 M(+6.8%) | $607.52 M(-0.5%) |
| Sep 2023 | - | $153.88 M(+13.5%) | $610.53 M(-3.7%) |
| Jun 2023 | - | $135.56 M(-11.8%) | $634.01 M(-5.2%) |
| Mar 2023 | - | $153.76 M(-8.1%) | $668.50 M(+0.2%) |
| Dec 2022 | $667.24 M(+15.1%) | $167.33 M(-5.7%) | $667.24 M(+1.3%) |
| Sep 2022 | - | $177.35 M(+4.3%) | $658.96 M(+4.6%) |
| Jun 2022 | - | $170.05 M(+11.5%) | $630.07 M(+4.8%) |
| Mar 2022 | - | $152.51 M(-4.1%) | $601.35 M(+3.7%) |
| Dec 2021 | $579.77 M(+11.4%) | $159.05 M(+7.1%) | $579.77 M(+2.7%) |
| Sep 2021 | - | $148.46 M(+5.0%) | $564.28 M(-1.2%) |
| Jun 2021 | - | $141.33 M(+7.9%) | $570.95 M(+2.6%) |
| Mar 2021 | - | $130.93 M(-8.8%) | $556.35 M(+6.9%) |
| Dec 2020 | $520.40 M(+32.5%) | $143.56 M(-7.5%) | $520.40 M(+9.0%) |
| Sep 2020 | - | $155.13 M(+22.4%) | $477.29 M(+12.5%) |
| Jun 2020 | - | $126.73 M(+33.4%) | $424.29 M(+5.5%) |
| Mar 2020 | - | $94.98 M(-5.4%) | $402.26 M(+2.4%) |
| Dec 2019 | $392.75 M(-3.9%) | $100.45 M(-1.7%) | $392.75 M(-3.8%) |
| Sep 2019 | - | $102.14 M(-2.4%) | $408.24 M(-0.2%) |
| Jun 2019 | - | $104.69 M(+22.5%) | $409.10 M(+1.3%) |
| Mar 2019 | - | $85.47 M(-26.3%) | $403.94 M(-1.2%) |
| Dec 2018 | $408.90 M(+35.3%) | $115.93 M(+12.6%) | $408.90 M(+7.2%) |
| Sep 2018 | - | $103.00 M(+3.5%) | $381.40 M(+6.3%) |
| Jun 2018 | - | $99.54 M(+10.1%) | $358.80 M(+7.1%) |
| Mar 2018 | - | $90.43 M(+2.3%) | $335.09 M(+10.9%) |
| Dec 2017 | $302.24 M | $88.44 M(+10.0%) | $302.24 M(+9.4%) |
| Sep 2017 | - | $80.40 M(+6.0%) | $276.18 M(+9.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2017 | - | $75.83 M(+31.7%) | $252.59 M(+10.6%) |
| Mar 2017 | - | $57.58 M(-7.7%) | $228.39 M(+6.2%) |
| Dec 2016 | $215.00 M(+45.8%) | $62.37 M(+9.8%) | $215.00 M(+9.5%) |
| Sep 2016 | - | $56.81 M(+10.0%) | $196.32 M(+9.8%) |
| Jun 2016 | - | $51.63 M(+16.8%) | $178.87 M(+9.8%) |
| Mar 2016 | - | $44.19 M(+1.2%) | $162.92 M(+10.5%) |
| Dec 2015 | $147.47 M(+59.1%) | $43.69 M(+11.0%) | $147.47 M(+9.2%) |
| Sep 2015 | - | $39.36 M(+10.3%) | $135.01 M(+14.1%) |
| Jun 2015 | - | $35.68 M(+24.1%) | $118.34 M(+5.3%) |
| Mar 2015 | - | $28.74 M(-8.0%) | $112.33 M(+21.2%) |
| Dec 2014 | $92.68 M(+671.1%) | $31.23 M(+37.7%) | $92.68 M(+29.1%) |
| Sep 2014 | - | $22.69 M(-23.5%) | $71.78 M(+42.6%) |
| Jun 2014 | - | $29.68 M(+226.8%) | $50.35 M(+140.3%) |
| Mar 2014 | - | $9.08 M(-12.1%) | $20.95 M(+74.3%) |
| Dec 2013 | $12.02 M(+712.1%) | $10.34 M(+722.2%) | $12.02 M(+333.3%) |
| Sep 2013 | - | $1.26 M(+347.3%) | $2.77 M(+72.5%) |
| Jun 2013 | - | $281.00 K(+91.2%) | $1.61 M(+13.4%) |
| Mar 2013 | - | $147.00 K(-86.5%) | $1.42 M(-4.1%) |
| Dec 2012 | $1.48 M(+84.3%) | $1.09 M(+1096.7%) | $1.48 M(+242.4%) |
| Sep 2012 | - | $91.00 K(0.0%) | $432.00 K(+22.7%) |
| Jun 2012 | - | $91.00 K(-56.3%) | $352.00 K(-65.2%) |
| Mar 2012 | - | $208.00 K(+395.2%) | $1.01 M(+25.9%) |
| Dec 2011 | $803.00 K(+657.5%) | $42.00 K(+281.8%) | $803.00 K(-110.2%) |
| Sep 2011 | - | $11.00 K(-98.5%) | -$7.87 M(-0.1%) |
| Jun 2011 | - | $750.00 K(-108.7%) | -$7.88 M(-8.7%) |
| Dec 2010 | $106.00 K(-99.7%) | -$8.63 M(+67.8%) | -$8.63 M(+67.8%) |
| Dec 2009 | $37.92 M(+326.7%) | -$5.14 M | -$5.14 M |
| Dec 2008 | $8.89 M(+110.0%) | - | - |
| Dec 2007 | $4.23 M | - | - |
FAQ
- What is Supernus Pharmaceuticals annual revenue?
- What is the all time high annual revenue for Supernus Pharmaceuticals?
- What is Supernus Pharmaceuticals annual revenue year-on-year change?
- What is Supernus Pharmaceuticals quarterly revenue?
- What is the all time high quarterly revenue for Supernus Pharmaceuticals?
- What is Supernus Pharmaceuticals quarterly revenue year-on-year change?
- What is Supernus Pharmaceuticals TTM revenue?
- What is the all time high TTM revenue for Supernus Pharmaceuticals?
- What is Supernus Pharmaceuticals TTM revenue year-on-year change?
What is Supernus Pharmaceuticals annual revenue?
The current annual revenue of SUPN is $607.52 M
What is the all time high annual revenue for Supernus Pharmaceuticals?
Supernus Pharmaceuticals all-time high annual revenue is $667.24 M
What is Supernus Pharmaceuticals annual revenue year-on-year change?
Over the past year, SUPN annual revenue has changed by -$59.72 M (-8.95%)
What is Supernus Pharmaceuticals quarterly revenue?
The current quarterly revenue of SUPN is $175.69 M
What is the all time high quarterly revenue for Supernus Pharmaceuticals?
Supernus Pharmaceuticals all-time high quarterly revenue is $177.35 M
What is Supernus Pharmaceuticals quarterly revenue year-on-year change?
Over the past year, SUPN quarterly revenue has changed by +$21.81 M (+14.17%)
What is Supernus Pharmaceuticals TTM revenue?
The current TTM revenue of SUPN is $651.97 M
What is the all time high TTM revenue for Supernus Pharmaceuticals?
Supernus Pharmaceuticals all-time high TTM revenue is $668.50 M
What is Supernus Pharmaceuticals TTM revenue year-on-year change?
Over the past year, SUPN TTM revenue has changed by +$41.44 M (+6.79%)